Urea synthesis after oral protein ingestion in man.

The Journal of Clinical Investigation
R J Rafoth, G R Onstad

Abstract

In an attempt to assess hepatic functional capacity, hourly urea production, and corresponding serum amino acid concentrations after the ingestion of single protein meals (60, 120, and 240 g of protein) were evaluated in 18 normal subjects and in 8 patients with liver disease. In normal subjects, the relationship between urea production and serum amino acid concentration was linear (urea production in milligram urea nitrogen/kilogram lean body mass/hour = 6.3 times mg amino acid nitrogen/100 ml minus 20.5 SE of the estimate 6.9, r = 0.74, P less than 0.001), and variation of protein intake from 50 to 150 g/day for 3 days before testing did not change this relationship. The patients demonstrated impairment of urea synthesis proportional to the clinical severity of their liver disease. The potential clinical applications of these findings need to be determined.

References

Sep 1, 1973·The Journal of Clinical Investigation·D RudmanW D Warren
Apr 1, 1971·Journal of Clinical Pathology·R Hume, E Weyers
Sep 1, 1959·The Journal of Clinical Investigation·M WALSER, L J BODENLOS

❮ Previous
Next ❯

Citations

Jun 1, 1999·Nutrition Research Reviews·J C Waterlow
Apr 26, 1980·British Medical Journal·S J O'KeefeR Y Calne
Aug 16, 2011·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Tazeen H JafarAndrew S Levey
Nov 1, 1994·Metabolism: Clinical and Experimental·A Taveroff, L J Hoffer
Oct 1, 1993·Metabolism: Clinical and Experimental·S W Brusilow, J Finkelstien
Nov 1, 1992·Critical Reviews in Oncology/hematology·G Daugaard, U Abildgaard
Sep 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T G BrewerM A Dunn
Jul 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·P SchauderU Langenbeck
Oct 20, 2004·Advances in Chronic Kidney Disease·Naveen SingriMurray L Levin
Jul 6, 2016·PloS One·Emilie GlavindKaren Louise Thomsen
Sep 1, 1981·JPEN. Journal of Parenteral and Enteral Nutrition·W P SteffeeV R Young
Jul 1, 1986·JPEN. Journal of Parenteral and Enteral Nutrition·D T DempseyJ L Mullen
Nov 9, 2017·Scandinavian Journal of Gastroenterology·Emilie GlavindKaren Louise Thomsen
Oct 10, 2001·Circulation·S T St JeorUNKNOWN Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association
Feb 1, 1994·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·F TrevisaniG Gasbarrini
Aug 1, 2014·Clinical Journal of the American Society of Nephrology : CJASN·I David WeinerJeff M Sands
Aug 25, 2007·American Journal of Physiology. Gastrointestinal and Liver Physiology·Marcel C G van de PollCornelis H C Dejong
Dec 7, 2007·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M JourdanC Aussel
Dec 1, 1992·Journal of the American College of Nutrition·M A KhanF Q Nuttall
Jan 1, 1997·The American Journal of Physiology·L J HofferA Schiffrin
Apr 8, 1998·The American Journal of Physiology·M J Hamadeh, L J Hoffer
Jun 27, 2020·World Journal of Gastroenterology : WJG·Tea L LaursenHenning Grønbæk
Nov 1, 1987·The American Journal of Physiology·F Jahoor, R R Wolfe
Jan 1, 1979·Biochemical Pharmacology·G O PerezE R Schiff
Jul 1, 1990·Metabolism: Clinical and Experimental·F Q Nuttall, M C Gannon
Oct 1, 1992·Metabolism: Clinical and Experimental·M C GannonL A Burmeister
Mar 1, 1994·Metabolism: Clinical and Experimental·A TaveroffL J Hoffer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.